[1] Younossi ZM, Golabi P, Paik J,et al. Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver Int, 2024,44(4):1061-1070. [2] Huang J, Xue W, Wang M,et al. MAFLD criteria may overlook a subtype of patient with steatohepatitis and significant fibrosis. Diabetes Metab Syndr Obes, 2021,14:3417-3425. [3] Yin JY, Yang TY, Yang BQ, et al. FibroScan-aspartate transaminase: a superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis. World J Gastroenterol, 2024,30(18):2440-2453. [4] Kong W, Tang Y, Liu L,et al. Stratifying non-alcoholic steatohepatitis with the non-invasive ultrasound markers shear wave dispersion slope and shear wave velocity: an animal study. Ultrasound Med Biol, 2022,48(12):2442-2448. [5] Basavarajappa L, Baek J, Reddy S, et al. Multiparametric ultrasound imaging for the assessment of normal versus steatotic livers. Sci Rep, 2021,11(1):2655. [6] 中华医学会肝病学分会.代谢相关(非酒精性)脂肪性肝病防治指南(2024年版).实用肝脏病杂志,2024,27(4): 494-510. [7] 王永康,魏诗雨,刘昌,等. 脂肪性肝病新定义:从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病. 中华消化外科杂志,2023,22(S1):117-121. [8] 陈凯,居峰. 多烯磷脂酰胆碱联合扶正化瘀片治疗非酒精性脂肪性肝病患者肝脏超声脂肪变性评分变化. 实用肝脏病杂志,2022,25(2):219-222. [9] Tada T, Nishimura T, Yoshida M,et al. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography. J Med Ultrason (2001), 2020,47(4):511-520. [10] Sugimoto K, Moriyasu F, Oshiro H, et al. The role of multiparametric US of the liver for the evaluation of nonalcoholic steatohepatitis. Radiology, 2020,296(3):532-540. [11] Wang K, Yu D, Li G, et al. Comparison of the diagnostic performance of shear wave elastography with shear wave dispersion for pre-operative staging of hepatic fibrosis in patients with hepatocellular carcinoma. Eur J Radiol, 2022,154:110459. [12] Cetiner M, Schiepek F, Finkelberg I, et al. Validation of attenuation imaging coefficient, shear wave elastography, and dispersion as emerging tools for non-invasive evaluation of liver tissue in children. Front Pediatr, 2023,11:1020690. [13] 李雪齐,程广文,乔晓慧,等. 多参数超声定量评估高风险脂肪性肝炎的临床价值. 中华肝脏病杂志,2024,32(9):820-827. [14] Younossi ZM, Mangla KK, Berentzen TL, et al. Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis. Hepatol Commun, 2024,8(6):e0423. [15] Smith AK, Ropella GEP, McGill MR, et al. Contrasting model mechanisms of alanine aminotransferase (ALT) release from damaged and necrotic hepatocytes as an example of general biomarker mechanisms. PLoS Comput Biol, 2020, 16(6):e1007622. [16] Stadler JT, Marsche G. Obesity-related changes in high-density lipoprotein metabolism and function. Int J Mol Sci, 2020,21(23):8985. [17] Kim Y, Hwang J, Bae SH, et al. Clinical feasibility of shear wave dispersion slope for noninvasive diagnosis of nonalcoholic steatohepatitis in patients with morbid obesity: preliminary results using US shear wave elastography. Ultrasound Q, 2022,38(2):149-154. [18] Ferraioli G, Barr RG. Ultrasound liver elastography beyond liver fibrosis assessment. World J Gastroenterol, 2020,26(24):3413-3420. [19] Garcovich M, Paratore M, Riccardi L,et al. Correlation between a new point-shear wave elastography device (X+pSWE) with liver histology and 2D-SWE (SSI) for liverstiffness quantification in chronic liver disease. Diagnostics (Basel), 2023,13(10):1743. [20] Sugimoto K, Lee DH, Lee JY, et al. Multiparametric US for identifying patients with high-risk NASH: a derivation and validation study. Radiology, 2021,301(3):625-634. |